146 related articles for article (PubMed ID: 11216552)
1. High peritoneal permeability predisposes to hepatic steatosis in diabetic continuous ambulatory peritoneal dialysis patients receiving intraperitoneal insulin.
Nevalainen PI; Kallio T; Lahtela JT; Mustonen J; Pasternack AI
Perit Dial Int; 2000; 20(6):637-42. PubMed ID: 11216552
[TBL] [Abstract][Full Text] [Related]
2. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
[TBL] [Abstract][Full Text] [Related]
3. Hepatic subcapsular steatosis in a diabetic CAPD patient receiving intraperitoneal insulin.
Jang EC; Kim G; Kim YS; Yoon SA; Ku YM; Yang CW; Kim YO
Korean J Intern Med; 2006 Sep; 21(3):206-9. PubMed ID: 17017674
[TBL] [Abstract][Full Text] [Related]
4. Hepatic subcapsular steatosis in diabetic CAPD patients treated with intraperitoneal insulin. Description of a typical pattern.
Kallio T; Nevalainen PI; Lahtela JT; Mustonen J; Pasternack A
Acta Radiol; 2001 May; 42(3):323-5. PubMed ID: 11350293
[TBL] [Abstract][Full Text] [Related]
5. Rare presentation of subcapsular hepatic steatosis in a woman with uncontrolled diabetes without peritoneal dialysis: a case report.
Chowdhary V; Pernicka JS; Sharma R
J Med Case Rep; 2016 Dec; 10(1):370. PubMed ID: 27998312
[TBL] [Abstract][Full Text] [Related]
6. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
8. Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence.
Khalili K; Lan FP; Hanbidge AE; Muradali D; Oreopoulos DG; Wanless IR
AJR Am J Roentgenol; 2003 Jun; 180(6):1601-4. PubMed ID: 12760927
[TBL] [Abstract][Full Text] [Related]
9. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
[TBL] [Abstract][Full Text] [Related]
10. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
Serlie MJ; Struijk DG; de Blok K; Krediet RT
Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646
[TBL] [Abstract][Full Text] [Related]
11. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
[TBL] [Abstract][Full Text] [Related]
12. Calculation of 6-hour D/P creatinine ratio from the 4-hour peritoneal equilibration test. The effect of dwell duration on the results.
Mehrotra R; Khanna R; Yang TC; Kathuria P; Moore HL; Prowant BF; Nolph KD; Twardowski ZJ
Perit Dial Int; 1997; 17(3):273-8. PubMed ID: 9237289
[TBL] [Abstract][Full Text] [Related]
13. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
Madden MA; Zimmerman SW; Simpson DP
Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials.
Almalki MH; Altuwaijri MA; Almehthel MS; Sirrs SM; Singh RS
Clin Invest Med; 2012 Jun; 35(3):E132-43. PubMed ID: 22673316
[TBL] [Abstract][Full Text] [Related]
15. The effect of insulin delivery route on lipoproteins in type I diabetic patients on CAPD.
Nevalainen PI; Lahtela JT; Mustonen J; Taskinen MR; Pasternack A
Perit Dial Int; 1999; 19(2):148-53. PubMed ID: 10357186
[TBL] [Abstract][Full Text] [Related]
16. Imaging appearance of severe subcapsular hepatic steatosis: mimicking hepatic embolic infarcts.
H'ng MW; Kwek JW
Br J Radiol; 2010 May; 83(989):e98-100. PubMed ID: 20418464
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review.
Tzamaloukas AH; Oreopoulos DG
Adv Perit Dial; 1991; 7():81-5. PubMed ID: 1680463
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients.
Rojas-Campos E; Cortés-Sanabria L; Martínez-Ramírez HR; González L; Martín-del-Campo F; González-Ortiz M; Cueto-Manzano AM
Perit Dial Int; 2005; 25(6):576-82. PubMed ID: 16411525
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal transport status correlates with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients: a 2-year prospective study.
Szeto CC; Law MC; Wong TY; Leung CB; Li PK
Am J Kidney Dis; 2001 Feb; 37(2):329-36. PubMed ID: 11157374
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal accumulation of AGE and peritoneal membrane permeability.
Park MS; Lee HA; Chu WS; Yang DH; Hwang SD
Perit Dial Int; 2000; 20(4):452-60. PubMed ID: 11007378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
